Intercept Pharmaceuticals Inc logo

Intercept Pharmaceuticals Inc

FRA:I4P (USA)  
€ 12.65 (-2.24%) Mar 23
P/E:
2.12
P/B:
6.11
Market Cap:
€ 524.82M ($ 564.65M)
Enterprise V:
€ 384.16M ($ 413.32M)
Volume:
80.00
Avg Vol (2M):
84.00
Also Trade In:
Volume:
80.00
Market Cap €:
524.82M
Market Cap $:
564.65M
PE Ratio:
2.12
Avg Vol (2M):
84.00
Enterprise Value €:
384.16M
Enterprise Value $:
413.32M
PB Ratio:
6.11

Business Description

Description
Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.
Name Current Vs Industry Vs History
Cash-To-Debt 1.46
Equity-to-Asset 0.17
Debt-to-Equity 3.57
Debt-to-EBITDA -2.4
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.25
Distress
Grey
Safe
Beneish M-Score 0.38
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 2.83
9-Day RSI 11.03
14-Day RSI 20.85
6-1 Month Momentum % 18.38
12-1 Month Momentum % 14.56

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.35
Quick Ratio 2.35
Cash Ratio 2.11
Days Sales Outstanding 35.91
Days Payable 3613.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.1

Financials (Next Earnings Date:2023-05-05 Est.)

FRA:I4P's 30-Y Financials

How Intercept Pharmaceuticals Inc (FRA:I4P) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 299.573
EPS (TTM) (€) 6.642
Beta 0.98
Volatility % 69.89
14-Day RSI 20.85
14-Day ATR (€) 0.516993
20-Day SMA (€) 16.40725
12-1 Month Momentum % 14.56
52-Week Range (€) 10.555 - 20
Shares Outstanding (Mil) 41.67

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Intercept Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Intercept Pharmaceuticals Inc Stock Events

Event Date Price(€)
No Event Data

Intercept Pharmaceuticals Inc Frequently Asked Questions

What is Intercept Pharmaceuticals Inc(FRA:I4P)'s stock price today?
The current price of FRA:I4P is €12.65. The 52 week high of FRA:I4P is €20.00 and 52 week low is €10.56.
When is next earnings date of Intercept Pharmaceuticals Inc(FRA:I4P)?
The next earnings date of Intercept Pharmaceuticals Inc(FRA:I4P) is 2023-05-05 Est..
Does Intercept Pharmaceuticals Inc(FRA:I4P) pay dividends? If so, how much?
Intercept Pharmaceuticals Inc(FRA:I4P) does not pay dividend.

Press Release

Subject Date
No Press Release